Focused on the unique needs of device and diagnostics manufacturers, ICON has broad experience in supporting trials of respiratory disease and infectious disease affecting respiratory function.

The prevalence of respiratory diseases will continue to rise as our global population ages and the incidence of chronic diseases, such as COPD and asthma, increases exponentially.

ICON has considerable experience in supporting trials of respiratory disease, infectious disease affecting respiratory function, and supporting investigational treatments in the biotech, pharmaceutical, medical device and diagnostic industries.

Respiratory

Infectious Disease affecting respiratory function

Alpha-1-Antitrypsin deficiency (AATD)

Lower respiratory tract infections

Asthma

Gram negative bacterial infections

Bronchiectasis

Influenza

COPD

Invasive aspergillosis

Cystic Fibrosis

Pertussis

Hantavirus Pulmonary Syndrome

Pneumonia

Idiopathic Pulmonary Fibrosis

Primary pulmonary coccidioidomycosis

Pulmonary Sarcoidosis

Respiratory syncytial virus

 

Tuberculosis

 

Valley Fever

Medical Device examples include:

  • Anesthesia systems and monitors
  • Asthma diagnostic
  • Automated closed loop ventilation system
  • CPR assist devices / resuscitators
  • Chest drainage system
  • Closed airway suction system
  • Extracorporeal membrane ventilators
  • Tracheostomy tubes and accessories
  • Oxygen delivery / flowmeter devices
  • Smart Inhalers

Additionally, our Medical Device & Diagnostics experts have assisted with studies to aid in the diagnosis of respiratory conditions or utilising inhalitive or intranasal mechanisms for targeted drug delivery.

Diagnostic devices have included:

  • Bronchoscopy endoscopes
  • Mobile medical applications
  • In Vitro Diagnostics
  • Medical imaging software

COVID-19 clinical operations

Keeping your clinical trial on track in an evolving environment.